Request for Covid-19 Impact Assessment of this Report
The United States Pediatric Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pediatric Vaccines market, reaching US$ million by the year 2028. As for the Europe Pediatric Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pediatric Vaccines players cover GlaxoSmithKline, Merck, Pfizer, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Newborn
Infant
Child
Dolescent
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pediatric Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pediatric Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pediatric Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Pediatric Vaccines Segment by Type
2.2.1 Diphtheria
2.2.2 Influenza
2.2.3 Hepatitis
2.2.4 Pneumococcal Diseases
2.2.5 Meningococcal Diseases
2.2.6 Others
2.3 Pediatric Vaccines Sales by Type
2.3.1 Global Pediatric Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Pediatric Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pediatric Vaccines Sale Price by Type (2017-2022)
2.4 Pediatric Vaccines Segment by Application
2.4.1 Newborn
2.4.2 Infant
2.4.3 Child
2.4.4 Dolescent
2.5 Pediatric Vaccines Sales by Application
2.5.1 Global Pediatric Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Pediatric Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pediatric Vaccines Sale Price by Application (2017-2022)
3 Global Pediatric Vaccines by Company
3.1 Global Pediatric Vaccines Breakdown Data by Company
3.1.1 Global Pediatric Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Pediatric Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Pediatric Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Pediatric Vaccines Revenue by Company (2020-2022)
3.2.2 Global Pediatric Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Pediatric Vaccines Sale Price by Company
3.4 Key Manufacturers Pediatric Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pediatric Vaccines Product Location Distribution
3.4.2 Players Pediatric Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pediatric Vaccines by Geographic Region
4.1 World Historic Pediatric Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Pediatric Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pediatric Vaccines Annual Revenue by Geographic Region
4.2 World Historic Pediatric Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Pediatric Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pediatric Vaccines Annual Revenue by Country/Region
4.3 Americas Pediatric Vaccines Sales Growth
4.4 APAC Pediatric Vaccines Sales Growth
4.5 Europe Pediatric Vaccines Sales Growth
4.6 Middle East & Africa Pediatric Vaccines Sales Growth
5 Americas
5.1 Americas Pediatric Vaccines Sales by Country
5.1.1 Americas Pediatric Vaccines Sales by Country (2017-2022)
5.1.2 Americas Pediatric Vaccines Revenue by Country (2017-2022)
5.2 Americas Pediatric Vaccines Sales by Type
5.3 Americas Pediatric Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pediatric Vaccines Sales by Region
6.1.1 APAC Pediatric Vaccines Sales by Region (2017-2022)
6.1.2 APAC Pediatric Vaccines Revenue by Region (2017-2022)
6.2 APAC Pediatric Vaccines Sales by Type
6.3 APAC Pediatric Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pediatric Vaccines by Country
7.1.1 Europe Pediatric Vaccines Sales by Country (2017-2022)
7.1.2 Europe Pediatric Vaccines Revenue by Country (2017-2022)
7.2 Europe Pediatric Vaccines Sales by Type
7.3 Europe Pediatric Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pediatric Vaccines by Country
8.1.1 Middle East & Africa Pediatric Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pediatric Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Pediatric Vaccines Sales by Type
8.3 Middle East & Africa Pediatric Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pediatric Vaccines
10.3 Manufacturing Process Analysis of Pediatric Vaccines
10.4 Industry Chain Structure of Pediatric Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pediatric Vaccines Distributors
11.3 Pediatric Vaccines Customer
12 World Forecast Review for Pediatric Vaccines by Geographic Region
12.1 Global Pediatric Vaccines Market Size Forecast by Region
12.1.1 Global Pediatric Vaccines Forecast by Region (2023-2028)
12.1.2 Global Pediatric Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pediatric Vaccines Forecast by Type
12.7 Global Pediatric Vaccines Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Pediatric Vaccines Product Offered
13.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Pediatric Vaccines Product Offered
13.2.3 Merck Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Pediatric Vaccines Product Offered
13.3.3 Pfizer Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Pediatric Vaccines Product Offered
13.4.3 Sanofi Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Pediatric Vaccines Product Offered
13.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Pediatric Vaccines Product Offered
13.6.3 Novartis Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Information
13.7.2 Takeda Pharmaceutical Pediatric Vaccines Product Offered
13.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Takeda Pharmaceutical Main Business Overview
13.7.5 Takeda Pharmaceutical Latest Developments
13.8 Bavarian Nordic
13.8.1 Bavarian Nordic Company Information
13.8.2 Bavarian Nordic Pediatric Vaccines Product Offered
13.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bavarian Nordic Main Business Overview
13.8.5 Bavarian Nordic Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter Pediatric Vaccines Product Offered
13.9.3 Baxter Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 LG Life Sciences
13.10.1 LG Life Sciences Company Information
13.10.2 LG Life Sciences Pediatric Vaccines Product Offered
13.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 LG Life Sciences Main Business Overview
13.10.5 LG Life Sciences Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Pediatric Vaccines Product Offered
13.11.3 Lupin Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 S K Chemicals
13.12.1 S K Chemicals Company Information
13.12.2 S K Chemicals Pediatric Vaccines Product Offered
13.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 S K Chemicals Main Business Overview
13.12.5 S K Chemicals Latest Developments
13.13 Mitsubishi Tanabe Pharma
13.13.1 Mitsubishi Tanabe Pharma Company Information
13.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Offered
13.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Mitsubishi Tanabe Pharma Main Business Overview
13.13.5 Mitsubishi Tanabe Pharma Latest Developments
13.14 Janssen
13.14.1 Janssen Company Information
13.14.2 Janssen Pediatric Vaccines Product Offered
13.14.3 Janssen Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Janssen Main Business Overview
13.14.5 Janssen Latest Developments
13.15 Shenzhen Kangtai Biological Products
13.15.1 Shenzhen Kangtai Biological Products Company Information
13.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Offered
13.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shenzhen Kangtai Biological Products Main Business Overview
13.15.5 Shenzhen Kangtai Biological Products Latest Developments
13.16 Sinovac Biotech
13.16.1 Sinovac Biotech Company Information
13.16.2 Sinovac Biotech Pediatric Vaccines Product Offered
13.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sinovac Biotech Main Business Overview
13.16.5 Sinovac Biotech Latest Developments
13.17 Bharat Biotech
13.17.1 Bharat Biotech Company Information
13.17.2 Bharat Biotech Pediatric Vaccines Product Offered
13.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Bharat Biotech Main Business Overview
13.17.5 Bharat Biotech Latest Developments
13.18 Crucell
13.18.1 Crucell Company Information
13.18.2 Crucell Pediatric Vaccines Product Offered
13.18.3 Crucell Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Crucell Main Business Overview
13.18.5 Crucell Latest Developments
13.19 Dynavax
13.19.1 Dynavax Company Information
13.19.2 Dynavax Pediatric Vaccines Product Offered
13.19.3 Dynavax Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Dynavax Main Business Overview
13.19.5 Dynavax Latest Developments
13.20 Serum Institute of India
13.20.1 Serum Institute of India Company Information
13.20.2 Serum Institute of India Pediatric Vaccines Product Offered
13.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Serum Institute of India Main Business Overview
13.20.5 Serum Institute of India Latest Developments
14 Research Findings and Conclusion
Table 1. Pediatric Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pediatric Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diphtheria
Table 4. Major Players of Influenza
Table 5. Major Players of Hepatitis
Table 6. Major Players of Pneumococcal Diseases
Table 7. Major Players of Meningococcal Diseases
Table 8. Major Players of Others
Table 9. Global Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 10. Global Pediatric Vaccines Sales Market Share by Type (2017-2022)
Table 11. Global Pediatric Vaccines Revenue by Type (2017-2022) & ($ million)
Table 12. Global Pediatric Vaccines Revenue Market Share by Type (2017-2022)
Table 13. Global Pediatric Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 15. Global Pediatric Vaccines Sales Market Share by Application (2017-2022)
Table 16. Global Pediatric Vaccines Revenue by Application (2017-2022)
Table 17. Global Pediatric Vaccines Revenue Market Share by Application (2017-2022)
Table 18. Global Pediatric Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global Pediatric Vaccines Sales by Company (2020-2022) & (K Units)
Table 20. Global Pediatric Vaccines Sales Market Share by Company (2020-2022)
Table 21. Global Pediatric Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Pediatric Vaccines Revenue Market Share by Company (2020-2022)
Table 23. Global Pediatric Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers Pediatric Vaccines Producing Area Distribution and Sales Area
Table 25. Players Pediatric Vaccines Products Offered
Table 26. Pediatric Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Pediatric Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Pediatric Vaccines Sales Market Share Geographic Region (2017-2022)
Table 31. Global Pediatric Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Pediatric Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Pediatric Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Pediatric Vaccines Sales Market Share by Country/Region (2017-2022)
Table 35. Global Pediatric Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Pediatric Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 38. Americas Pediatric Vaccines Sales Market Share by Country (2017-2022)
Table 39. Americas Pediatric Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Pediatric Vaccines Revenue Market Share by Country (2017-2022)
Table 41. Americas Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 42. Americas Pediatric Vaccines Sales Market Share by Type (2017-2022)
Table 43. Americas Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 44. Americas Pediatric Vaccines Sales Market Share by Application (2017-2022)
Table 45. APAC Pediatric Vaccines Sales by Region (2017-2022) & (K Units)
Table 46. APAC Pediatric Vaccines Sales Market Share by Region (2017-2022)
Table 47. APAC Pediatric Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Pediatric Vaccines Revenue Market Share by Region (2017-2022)
Table 49. APAC Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 50. APAC Pediatric Vaccines Sales Market Share by Type (2017-2022)
Table 51. APAC Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 52. APAC Pediatric Vaccines Sales Market Share by Application (2017-2022)
Table 53. Europe Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 54. Europe Pediatric Vaccines Sales Market Share by Country (2017-2022)
Table 55. Europe Pediatric Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Pediatric Vaccines Revenue Market Share by Country (2017-2022)
Table 57. Europe Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 58. Europe Pediatric Vaccines Sales Market Share by Type (2017-2022)
Table 59. Europe Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 60. Europe Pediatric Vaccines Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Pediatric Vaccines Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Pediatric Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Pediatric Vaccines Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Pediatric Vaccines Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Pediatric Vaccines
Table 70. Key Market Challenges & Risks of Pediatric Vaccines
Table 71. Key Industry Trends of Pediatric Vaccines
Table 72. Pediatric Vaccines Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Pediatric Vaccines Distributors List
Table 75. Pediatric Vaccines Customer List
Table 76. Global Pediatric Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Pediatric Vaccines Sales Market Forecast by Region
Table 78. Global Pediatric Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Pediatric Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Pediatric Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Pediatric Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Pediatric Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Pediatric Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Pediatric Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Pediatric Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Pediatric Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Pediatric Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Pediatric Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Pediatric Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Pediatric Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Pediatric Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Pediatric Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Pediatric Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Pediatric Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 96. GlaxoSmithKline Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. GlaxoSmithKline Pediatric Vaccines Product Offered
Table 98. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. GlaxoSmithKline Main Business
Table 100. GlaxoSmithKline Latest Developments
Table 101. Merck Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Merck Pediatric Vaccines Product Offered
Table 103. Merck Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. Pfizer Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Pediatric Vaccines Product Offered
Table 108. Pfizer Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. Sanofi Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Sanofi Pediatric Vaccines Product Offered
Table 113. Sanofi Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. Sanofi Main Business
Table 115. Sanofi Latest Developments
Table 116. AstraZeneca Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Pediatric Vaccines Product Offered
Table 118. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Novartis Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. Novartis Pediatric Vaccines Product Offered
Table 123. Novartis Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Novartis Main Business
Table 125. Novartis Latest Developments
Table 126. Takeda Pharmaceutical Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. Takeda Pharmaceutical Pediatric Vaccines Product Offered
Table 128. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. Takeda Pharmaceutical Main Business
Table 130. Takeda Pharmaceutical Latest Developments
Table 131. Bavarian Nordic Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Bavarian Nordic Pediatric Vaccines Product Offered
Table 133. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. Bavarian Nordic Main Business
Table 135. Bavarian Nordic Latest Developments
Table 136. Baxter Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. Baxter Pediatric Vaccines Product Offered
Table 138. Baxter Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. Baxter Main Business
Table 140. Baxter Latest Developments
Table 141. LG Life Sciences Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. LG Life Sciences Pediatric Vaccines Product Offered
Table 143. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 144. LG Life Sciences Main Business
Table 145. LG Life Sciences Latest Developments
Table 146. Lupin Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. Lupin Pediatric Vaccines Product Offered
Table 148. Lupin Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 149. Lupin Main Business
Table 150. Lupin Latest Developments
Table 151. S K Chemicals Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. S K Chemicals Pediatric Vaccines Product Offered
Table 153. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 154. S K Chemicals Main Business
Table 155. S K Chemicals Latest Developments
Table 156. Mitsubishi Tanabe Pharma Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Offered
Table 158. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 159. Mitsubishi Tanabe Pharma Main Business
Table 160. Mitsubishi Tanabe Pharma Latest Developments
Table 161. Janssen Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. Janssen Pediatric Vaccines Product Offered
Table 163. Janssen Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 164. Janssen Main Business
Table 165. Janssen Latest Developments
Table 166. Shenzhen Kangtai Biological Products Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 167. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Offered
Table 168. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 169. Shenzhen Kangtai Biological Products Main Business
Table 170. Shenzhen Kangtai Biological Products Latest Developments
Table 171. Sinovac Biotech Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 172. Sinovac Biotech Pediatric Vaccines Product Offered
Table 173. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 174. Sinovac Biotech Main Business
Table 175. Sinovac Biotech Latest Developments
Table 176. Bharat Biotech Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 177. Bharat Biotech Pediatric Vaccines Product Offered
Table 178. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 179. Bharat Biotech Main Business
Table 180. Bharat Biotech Latest Developments
Table 181. Crucell Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 182. Crucell Pediatric Vaccines Product Offered
Table 183. Crucell Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 184. Crucell Main Business
Table 185. Crucell Latest Developments
Table 186. Dynavax Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 187. Dynavax Pediatric Vaccines Product Offered
Table 188. Dynavax Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 189. Dynavax Main Business
Table 190. Dynavax Latest Developments
Table 191. Serum Institute of India Basic Information, Pediatric Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 192. Serum Institute of India Pediatric Vaccines Product Offered
Table 193. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 194. Serum Institute of India Main Business
Table 195. Serum Institute of India Latest Developments
List of Figures
Figure 1. Picture of Pediatric Vaccines
Figure 2. Pediatric Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pediatric Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pediatric Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diphtheria
Figure 10. Product Picture of Influenza
Figure 11. Product Picture of Hepatitis
Figure 12. Product Picture of Pneumococcal Diseases
Figure 13. Product Picture of Meningococcal Diseases
Figure 14. Product Picture of Others
Figure 15. Global Pediatric Vaccines Sales Market Share by Type in 2021
Figure 16. Global Pediatric Vaccines Revenue Market Share by Type (2017-2022)
Figure 17. Pediatric Vaccines Consumed in Newborn
Figure 18. Global Pediatric Vaccines Market: Newborn (2017-2022) & (K Units)
Figure 19. Pediatric Vaccines Consumed in Infant
Figure 20. Global Pediatric Vaccines Market: Infant (2017-2022) & (K Units)
Figure 21. Pediatric Vaccines Consumed in Child
Figure 22. Global Pediatric Vaccines Market: Child (2017-2022) & (K Units)
Figure 23. Pediatric Vaccines Consumed in Dolescent
Figure 24. Global Pediatric Vaccines Market: Dolescent (2017-2022) & (K Units)
Figure 25. Global Pediatric Vaccines Sales Market Share by Application (2017-2022)
Figure 26. Global Pediatric Vaccines Revenue Market Share by Application in 2021
Figure 27. Pediatric Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Pediatric Vaccines Revenue Market Share by Company in 2021
Figure 29. Global Pediatric Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Pediatric Vaccines Revenue Market Share by Geographic Region in 2021
Figure 31. Global Pediatric Vaccines Sales Market Share by Region (2017-2022)
Figure 32. Global Pediatric Vaccines Revenue Market Share by Country/Region in 2021
Figure 33. Americas Pediatric Vaccines Sales 2017-2022 (K Units)
Figure 34. Americas Pediatric Vaccines Revenue 2017-2022 ($ Millions)
Figure 35. APAC Pediatric Vaccines Sales 2017-2022 (K Units)
Figure 36. APAC Pediatric Vaccines Revenue 2017-2022 ($ Millions)
Figure 37. Europe Pediatric Vaccines Sales 2017-2022 (K Units)
Figure 38. Europe Pediatric Vaccines Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Pediatric Vaccines Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Pediatric Vaccines Revenue 2017-2022 ($ Millions)
Figure 41. Americas Pediatric Vaccines Sales Market Share by Country in 2021
Figure 42. Americas Pediatric Vaccines Revenue Market Share by Country in 2021
Figure 43. United States Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Pediatric Vaccines Sales Market Share by Region in 2021
Figure 48. APAC Pediatric Vaccines Revenue Market Share by Regions in 2021
Figure 49. China Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Pediatric Vaccines Sales Market Share by Country in 2021
Figure 56. Europe Pediatric Vaccines Revenue Market Share by Country in 2021
Figure 57. Germany Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Pediatric Vaccines Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Pediatric Vaccines Revenue Market Share by Country in 2021
Figure 64. Egypt Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Pediatric Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Pediatric Vaccines in 2021
Figure 70. Manufacturing Process Analysis of Pediatric Vaccines
Figure 71. Industry Chain Structure of Pediatric Vaccines
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...